Cargando…
Proton pump inhibitors and the risk of gallbladder cancer: a hospital-based case–control study
Autores principales: | Xiong, Jianping, Wang, Yaqin, Chen, Guang, Jin, Long |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677475/ https://www.ncbi.nlm.nih.gov/pubmed/32273291 http://dx.doi.org/10.1136/gutjnl-2020-321052 |
Ejemplares similares
-
Proton pump inhibitor use associated with changes in gut microbiota composition
por: Reveles, Kelly R, et al.
Publicado: (2018) -
Response by Abrahami et al to letter regarding article ‘Proton pump inhibitors and risk of colorectal cancer’
por: Abrahami, Devin, et al.
Publicado: (2022) -
Proton pump inhibitors and gastric cancer: a long expected side effect finally reported also in man
por: Waldum, Helge Lyder, et al.
Publicado: (2018) -
Do proton pump inhibitors influence SARS-CoV-2 related outcomes? A meta-analysis
por: Li, Guo-Fu, et al.
Publicado: (2021) -
Immune checkpoint inhibitors: use them early, combined and instead of TACE?
por: De Toni, Enrico N
Publicado: (2020)